Dentsply Sirona Inc. 8-K Filing
Ticker: XRAY · Form: 8-K · Filed: Nov 25, 2025 · CIK: 818479
| Field | Detail |
|---|---|
| Company | Dentsply Sirona Inc. (XRAY) |
| Form Type | 8-K |
| Filed Date | Nov 25, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Dentsply Sirona Inc. (ticker: XRAY) to the SEC on Nov 25, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (ich registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market).
How long is this filing?
Dentsply Sirona Inc.'s 8-K filing is 2 pages with approximately 552 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 552 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2025-11-25 07:28:54
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market
Filing Documents
- xray-20251125.htm (8-K) — 23KB
- 0000818479-25-000281.txt ( ) — 138KB
- xray-20251125.xsd (EX-101.SCH) — 2KB
- xray-20251125_lab.xml (EX-101.LAB) — 22KB
- xray-20251125_pre.xml (EX-101.PRE) — 13KB
- xray-20251125_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events On November 25, 2025, DENTSPLY SIRONA Inc. (the "Company") announced the appointment of Michael Pomeroy as the Company's interim Chief Financial Officer, who will serve in this temporary capacity until the Company identifies and appoints a permanent Chief Financial Officer. As interim Chief Financial Officer, Mr. Pomeroy will support Daniel T. Scavilla, the Company's President and Chief Executive Officer, who will continue to serve as the Company's principal financial officer (in addition to serving as the Company's principal executive officer) until the Company identifies and appoints a permanent Chief Financial Officer. Mr. Pomeroy began his career at GE (1981-2000), and his Finance leadership experiences have led global businesses and companies through successful growth, turnaround, operational improvement, and M&A activities. Those leadership experiences included the following industries: Industrial/Manufacturing, Healthcare, Consumer Retail, Distribution, and more. Most recently, Mr. Pomeroy served as interim Chief Financial Officer of Highridge Medical, a spinal devices company, from February 2025 to September 2025. Previously, he served as Executive Vice President and Chief Financial Officer of Icahn Automotive Group (2022-2024), Executive Vice President and Chief Financial Officer of Hollander-Keeco (2021-2022), a home textiles company, and Vice President and Chief Financial Officer of RGIS (2017-2021), a retail and warehousing services company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DENTSPLY SIRONA Inc. By: /s/ Daniel T. Scavilla Daniel T. Scavilla President and Chief Executive Officer Date: November 25, 2025